Uveal Melanoma TNM Staging and Survivorship
Version 101.3
Released: 1 July 2019

 

    Date:
Patient's Name: Hospital Number:
Practitioner's Name: Position:
   
Age years Epithelioid cells  
  Sex   Closed PAS +ve loops    
Large ultrasound diameter mm Mitotic rate /40  
  Ultrasound thickness mm   Chromosome 3 loss    
  Ciliary body involvement   Regional lymph nodes*    
  Extraocular extension   Distant metastasis*  
             
  Years since treatment years   First scan years  
        Time from Metastasis to death months  
        Number needed to scan  
 

 

 
Melanoma Patients General Population

* Parameters indicated by an asterisk are included for TNM staging only and have no effect on the survival curve

T: ... N: ... M: ... Stage: ...
Threshold for next scan at: ...

Survival: Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10
Controls: ... ... ... ... ... ... ... ... ... ...
Subjects: ... ... ... ... ... ... ... ... ... ...
Difference: ... ... ... ... ... ... ... ... ... ...
Relative: ... ... ... ... ... ... ... ... ... ...

 


Dept. of Medical Physics & Clinical Engineering, Royal Liverpool University Hospital

 

Reference: A. Eleuteri, B.E. Damato, S.E. Coupland, A.F.G. Taktak (2012). Enhancing survival prognostication in patients with choroidal melanoma by integrating pathologic, clinical and genetic predictors of metastasis. Int J Biomedical Eng and Tech, 8, 1, 18 - 35 (Link)  

Home | Terms and Conditions |Privacy | Background | Links | Contact us